CTLA-4 expression on CD4 cells was increased with 190% in cancer patients before treatment compared to healthy controls, and RT induced a further strong and persistent increase in CTLA-4 expression (212% increase one month after RT compared to pre-treatment levels) (Figure 4B). This evidence concerns the gene CTLA4 and cancer.